An experimental vaccine developed in Europe to prevent infection by Crimean-Congo hemorrhagic fever virus (CCHFV) has protected cynomolgus macaques in a new collaborative study from National Institutes of Health...
Vaccination generated robust and protective antigen-specific antibody and T cell immune responses in preclinical animal models. As the global spread of the Zika virus continues, efforts are underway to halt the...